Floatz logo

FLUTICASONE

Refractory Anemia With Ringed Sideroblasts

National Cancer Institute (NCI)Small moleculePhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Refractory Anemia With Ringed Sideroblasts cohort.

Asset / SponsorPhaseRating
CYCLOSPORIN A
National Cancer Institute (NCI)
Phase 2BB
Monomethyl Fumarate
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2BB
Fludarabine
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 3BB
FILGRASTIM
National Cancer Institute (NCI)
Phase 3BB
METHOTREXATE
National Cancer Institute (NCI)
Phase 3BB

View all 23 →

Same molecule, other indications

FLUTICASONE is also rated in:

Unspecified Adult Solid Tumor, Protocol SpecificDormant
BBB
Indicative ·
73 / 100
View asset →
Recurrent Adult Acute Myeloid LeukemiaDormant
BBB
Indicative ·
73 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →